The effects of antifungal agents on the morphogenetic transformation by Candida albicans in vitro

被引:14
作者
Hawser, S [1 ]
Francolini, M [1 ]
Islam, K [1 ]
机构
[1] UNIV MILAN,DEPT BIOL,I-20133 MILAN,ITALY
关键词
D O I
10.1093/jac/38.4.579
中图分类号
R51 [传染病];
学科分类号
100401 [流行病与卫生统计学];
摘要
The effects of antifungal agents, with different mechanisms of action, on the morphogenetic transformation by synchronised yeast-phase Candida albicans cells in vitro and their respective anti-Candida activities are described. MIC data demonstrated that the azoles, amphotericin B and echinocandin were the most active agents against four C. albicans strains. Morphogenetic transformation experiments demonstrated that amphotericin B was significantly better at preventing the transformation, under a variety of test conditions, than the azoles and flucytosine: amphotericin B abolished the transformation at low concentrations while the azoles only prevented the morphogenetic transformation at much higher concentrations (>100 x MIC).
引用
收藏
页码:579 / 587
页数:9
相关论文
共 15 条
[1]
[Anonymous], 1992, M27P NCCLS
[2]
COMPARATIVE-STUDY OF BROTH MACRODILUTION AND MICRODILUTION TECHNIQUES FOR IN-VITRO ANTIFUNGAL SUSCEPTIBILITY TESTING OF YEASTS BY USING THE NATIONAL-COMMITTEE-FOR-CLINICAL-LABORATORY-STANDARDS PROPOSED STANDARD [J].
BARCHIESI, F ;
COLOMBO, AL ;
MCGOUGH, DA ;
RINALDI, MG .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (10) :2494-2500
[3]
COLLABORATIVE COMPARISON OF BROTH MACRODILUTION AND MICRODILUTION ANTIFUNGAL SUSCEPTIBILITY TESTS [J].
ESPINELINGROFF, A ;
KISH, CW ;
KERKERING, TM ;
FROMTLING, RA ;
BARTIZAL, K ;
GALGIANI, JN ;
VILLAREAL, K ;
PFALLER, MA ;
GERARDEN, T ;
RINALDI, MG ;
FOTHERGILL, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (12) :3138-3145
[4]
SUSCEPTIBILITY TESTING OF FUNGI - CURRENT STATUS OF THE STANDARDIZATION PROCESS [J].
GALGIANI, JN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (12) :2517-2521
[5]
Spectrophotometric determination of the morphogenetic transformation by synchronous Candida albicans: Effects of antifungal agents [J].
Hawser, S ;
Islam, K .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (01) :67-73
[6]
JANSEN T, 1991, J MED VET MYCOL, V29, P293
[7]
JOHNSON EM, 1982, MYKOSEN, V25, P481
[8]
JOHNSON EM, 1983, J ANTIMICROB CHEMOTH, V12, P603
[9]
Odds F.C., 1988, CANDIDA CANDIDOSIS R
[10]
ODDS FC, 1985, J GEN MICROBIOL, V131, P2581